Compile Data Set for Download or QSAR
Report error Found 155 Enz. Inhib. hit(s) with all data for entry = 13184
TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765354(US12391687, Example 25)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765354(US12391687, Example 25)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765350(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765350(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765349(US12391687, Example 20)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765349(US12391687, Example 20)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765351(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765351(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765350(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765351(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765358(US12391687, Example 29)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765358(US12391687, Example 29)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765357(US12391687, Example 28)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765357(US12391687, Example 28)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765359(US12391687, Example 30)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765359(US12391687, Example 30)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765358(US12391687, Example 29)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765359(US12391687, Example 30)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765355(US12391687, Example 26)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765355(US12391687, Example 26)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765354(US12391687, Example 25)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765355(US12391687, Example 26)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765356(US12391687, Example 27)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765357(US12391687, Example 28)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765356(US12391687, Example 27)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765356(US12391687, Example 27)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765363(5-(1-(azetidin-3-ylmethyl)-1H-pyrazol-4-yl)-3-((2R...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765363(5-(1-(azetidin-3-ylmethyl)-1H-pyrazol-4-yl)-3-((2R...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765362(US12391687, Example 33)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765363(5-(1-(azetidin-3-ylmethyl)-1H-pyrazol-4-yl)-3-((2R...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765364(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765365(5-(1-(2,2-difluoroethyl)-1H-pyrazol-3-yl)-3-((2R,4...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765364(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765364(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765361(1-(4-(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropy...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765360(US12391687, Example 31)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765362(US12391687, Example 33)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765362(US12391687, Example 33)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765361(1-(4-(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropy...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765361(1-(4-(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropy...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765368(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765369(5-(1-(2,2-difluoroethyl)-4-methyl-1H-pyrazol-3-yl)...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765368(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765368(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolid...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765370(2-(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrro...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765370(2-(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrro...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765369(5-(1-(2,2-difluoroethyl)-4-methyl-1H-pyrazol-3-yl)...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetNT-3 growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765369(5-(1-(2,2-difluoroethyl)-4-methyl-1H-pyrazol-3-yl)...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetHigh affinity nerve growth factor receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765366(2-(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrro...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

TargetBDNF/NT-3 growth factors receptor(Human)
Shanghai Ennovabio Pharmaceuticals

US Patent
LigandPNGBDBM765366(2-(3-((2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrro...)
Affinity DataIC50: 1nMAssay Description:Table 1: Experimental MethodThe tested compounds were subjected to 3-fold serial dilution to reach a final concentration of 1 μM to 0.05 nM (10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/25/2025
Entry Details
US Patent

Displayed 1 to 50 (of 155 total ) | Next | Last >>
Jump to: